Viewing Study NCT06214195


Ignite Creation Date: 2025-12-24 @ 1:14 PM
Ignite Modification Date: 2026-02-02 @ 4:05 AM
Study NCT ID: NCT06214195
Status: RECRUITING
Last Update Posted: 2024-01-19
First Post: 2023-11-25
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: The Use of Shengmai San to Prevent Anthracycline Sequential Trastuzumab Therapy Related Cardiac Toxicity
Sponsor: Zhejiang Cancer Hospital
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Cardiotoxicity Induced by Drug Therapy for Breast Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None prevent View
None cardiotoxicity View
None trastuzumab View
None chemotherapy View
None anthracycline View